Explore the relationship between statin usage and Type 2 diabetes in this informative lecture by Dr. Gerald Reaven from Stanford University. Learn about the risk factors, identification methods, and the overall benefits of statin treatment compared to the increased diabetes risk. Gain insights into who is most susceptible to statin-associated diabetes, why it occurs, and the extent of the risk involved. Understand how the advantages of statin therapy outweigh the potential drawbacks, providing a comprehensive view of this important medical topic.
Statin-Associated Type 2 Diabetes - Who Gets It, Why, and Risk Assessment
Stanford University via YouTube
Overview
Syllabus
Gerald Reaven, MD on Statin-Associated Type 2 Diabetes
Taught by
Stanford Health Care
Tags
Related Courses
-
Type 2 Diabetes in Asian Americans
5.0 -
Type 2 Diabetes Mellitus Update - June 24, 2015
-
Hypercholesterolemia and New Guidelines - Dr. Karol E. Watson, MD | UCLA Primary Care Update 2015
-
Understanding Type 2 Diabetes: Beyond Glucose and Fat Metabolism
-
Berberine - A Game Changer for Type 2 Diabetes Management
-
Treatment of Type 2 Diabetes Mellitus: A Rational Approach Based on its Pathophysiology - 20 March 2024
Related articles
Reviews
3.0 rating, based on 1 Class Central review
-
Hello, my name is Omkar Bhosale, persuing Bachelor of Pharmacy in India. About this perticular course I've got some interesting things such as,It is an very informative course in which they have mentioned the benifits of the statin class of the lipid lowering drugs along with statins increases the 10% risk of type 2 diabetes, and different research studies done in people's are also explained in detail. I've learned something new and different from this course thank you.
